Neurotrophic Keratitis Market Trends Insights and Forecast Research 2022-2030 | Statistics, Competition Strategies, Business Analysis, Opportunities and Share Demand, Global Size and Future Investment Analysis with Covid-19 Impact

Kenneth Research, in its repository of market research reports, have recently added a report on Neurotrophic Keratitis Market which emphasizes on the latest trends, key opportunities, drivers, and the challenges associated with the growth of the market during the forecast period, i.e., 2022-2031. The Neurotrophic Keratitis Market is anticipated to grow primarily on account of the growing trade of ICT goods and services worldwide. According to the statistics by the World Bank, the exports of ICT goods globally increased from 11.164% of total goods exports in 2017 to 11.53% of total goods exports in 2019.

U S Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analysis and U.S. Census Bureau mention the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) average exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilst imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Neurotrophic Keratitis Market products.

Request For The Sample Report Here:

Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth. According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018.

Global Neurotrophic Keratitis Market is valued approximately USD 92 million in 2019 and is anticipated to grow with a healthy growth rate of more than 17% over the forecast period 2019-2026. Neurotrophic Keratitis (NK) is a neurodegenerative disease caused by the injury of trigeminal nerve that affects the cornea of an eye. In this disease, the patient drops the corneal sensitivity and thus cornea is unprotected to damages without treatment. If this disease is not treated and diagnosed properly, the patient can loss permanent eye vision. The treatment of neurotrophic keratitis is done by a team that includes neurologists, ophthalmologists and corneal specialists. Treatments are available based on the severity of the disease. Neurotrophic Keratitis treatment comprises topical antibiotics, bandage contact lenses, preservative artificial tears, amniotic membrane transplantation, keratoplasty, Recombinant human nerve growth factor (rhNGF), and so on. Growing number of approvals for new product innovation from regulatory authorities,  with the huge financial support to the researchers for developing novel treatments are the few factors responsible for high CAGR of the market over the forecast period. For instance, in August 2018, Dompe farmaceutici S.p.A. has received approval for cenegermin topical eyes drop from FDA, which is a recombinant human nerve growth factor for the therapy of neurotrophic keratitis. The cenegermin has also obtained an Orphan Drug designation, Breakthrough Therapy designation and Fast Track status from the FDA. This, in turn, is expected to accelerate the growth of Neurotrophic Keratitis market around the world. However, low healthcare budget in some of the developing countries is one of the major factors expected to hamper the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Neurotrophic Keratitis market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising product approvals, presence of well-established healthcare infrastructure, and increase in R&D activities in neurotrophic keratitis in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to growing geriatric population and increasing government investments in healthcare and R&D present in the countries like China and India.

Major market player included in this report are:
Allergan, Plc.
Abbott Laboratories, Inc.
Bausch & Lomb Incorporated
Bayer AG
Dompe farmaceutici S.p.A.
Johnson & Johnson
Novartis AG
ReGenTree, LLC.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:
Preservative Free Artificial Tears
Topical Antibiotics
Amniotic Membrane Transplantation
Recombinant Human Nerve Growth Factor (rhNGF)

Enquire before purchasing this report – >>

By Region:
North America
Asia Pacific
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026

Target Audience of the Global Neurotrophic Keratitis Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Million)
1.2.1. Neurotrophic Keratitis Market, by Region, 2018-2026 (USD Million)
1.2.2. Neurotrophic Keratitis Market, by Treatment Type, 2018-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Neurotrophic Keratitis Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Neurotrophic Keratitis Market Dynamics
3.1. Neurotrophic Keratitis Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Neurotrophic Keratitis Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Neurotrophic Keratitis Market, by Treatment Type
5.1. Market Snapshot
5.2. Global Neurotrophic Keratitis Market by Treatment Type, Performance – Potential Analysis
5.3. Global Neurotrophic Keratitis Market Estimates & Forecasts by Treatment Type 2016-2026 (USD Million)
5.4. Neurotrophic Keratitis Market, Sub Segment Analysis
5.4.1. Preservative Free Artificial Tears
5.4.2. Topical Antibiotics
5.4.3. Amniotic Membrane Transplantation
5.4.4. Tarsorrhaphy
5.4.5. Recombinant Human Nerve Growth Factor (rhNGF)
5.4.6. Others
Chapter 6. Global Neurotrophic Keratitis Market, Regional Analysis
6.1. Neurotrophic Keratitis Market, Regional Market Snapshot
6.2. North America Neurotrophic Keratitis Market
6.2.1. U.S. Neurotrophic Keratitis Market

Ask for it and browse full report>>

About Kenneth Research:

Kenneth Research provides scheduled syndicated reports that help industry professionals and organizations decipher market trends to take significant decisions and plan strategies. We cater to a wide range of industries including healthcare & pharmaceuticals, ICT & telecom, automotive & transportation, energy & power, chemicals, FMCG & food, aerospace & defence, among others. Our research team ensures to track and analyze the industry on a regular basis to offer strategic business consultancy services on a global level. We, at Kenneth Research, are adept at capturing descriptive insights on crucial topics to help our clients make their informed decisions.

Contact Us
Kenneth Research
Phone: +1 313 462 0911

Customized Medical Amblyopia Therapeutic Apparatus Market
Medical Simulation Market
Global Voice Prosthesis Devices Market
Sterile Tubing Welder Market
Personal Lubricants Market
Neonatal Phototherapy Devices Market

Related posts

Leave a Comment